Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds.

Gastrointestinal endoscopy - 1 Jan 2003

Rulyak Stephen J, Kimmey Michael B, Veenstra David L, Brentnall Teresa A

Abstract excerpt

BACKGROUND: Endoscopic screening of families predisposed to pancreatic cancer is increasingly used, but the cost-effectiveness of screening is unknown. METHODS: A decision analysis was used to compare one-time screening for pancreatic dysplasia with EUS to no screening in a hypothetical cohort of 100 members of familial pancreatic cancer kindreds. Abnormal EUS findings are confirmed with ERCP and patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Decision Trees
Share to Endosonography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Health Care Costs

Share to Markov Chains

Share to Mass Screening

Share to Models, Economic

Share to Pancreas

Source

Identifiers

PMID: 12518126
DOI: 10.1067/mge.2003.28

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds.PMID 12518126Read ↗

A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma.Semantic proximity Read ↗

Peutz-Jeghers syndrome and screening for pancreatic cancer.Semantic proximity Read ↗

Pancreatic cancer surveillance in a high-risk cohort. Is it worth the cost?Semantic proximity Read ↗

Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer.Semantic proximity Read ↗

Cancer surveillance of patients from familial pancreatic cancer kindreds.Semantic proximity Read ↗

Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis.Semantic proximity Read ↗

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.Semantic proximity Read ↗

Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.Semantic proximity Read ↗

Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.Semantic proximity Read ↗

A cost analysis of a pancreatic cancer screening protocol in high-risk populations.Semantic proximity Read ↗

Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis.Semantic proximity Read ↗

Cost-utility analysis of genetic screening in families of patients with germline MUTYH mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.